{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-000715","form_type":"8-K","ticker":"TECH","cik":"0000842023","company_name":"BIO-TECHNE Corp","filed_at":"2023-01-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.233504+00:00","generated_at":"2026-06-20T06:06:33.546914+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bio-Techne appoints Shane Bohnen as SVP, General Counsel; Brenda Furlow retires March 3, 2023","bullets":["Shane Bohnen, previously Associate General Counsel since 2019, becomes Senior VP, General Counsel effective March 3, 2023.","Brenda Furlow, EVP & General Counsel for nine years, retires March 3, 2023; will remain as consultant for special projects.","Bohnen's compensation: $331,500 base salary, 50% target cash bonus, one-time $500,000 RSU grant vesting over three years.","Bohnen has over 20 years legal experience including private practice and in-house at Smiths Medical and Resideo."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-000715","json":"https://secwatch.observer/filing/0001558370-23-000715.json","markdown":"https://secwatch.observer/filing/0001558370-23-000715.md","text":"https://secwatch.observer/filing/0001558370-23-000715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/tmb-20230126x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T06:06:33.546914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"577ff026c7","claim":"Brenda Furlow retired as general_counsel at BIO-TECHNE Corp.","evidence_excerpt":"Mr. Bohnen succeeds Brenda Furlow, who has announced her intention to retire on March 3, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"retired"}],"fact_type":"executive_change"},{"claim_id":"b364fb7a1f","claim":"Shane Bohnen was appointed as Senior Vice President, General Counsel and Corporate Secretary at BIO-TECHNE Corp.","evidence_excerpt":"appointed Mr. Shane Bohnen, age 48, as an executive officer of the Company in the position of Senior Vice President, General Counsel and Corporate Secretary, effective March 3, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President, General Counsel and Corporate Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}